RUA Life Sciences plc (RUA) ORD GBP0.05
RUA Life Sciences PLC, formerly AorTech International plc, is a biomaterials and medical device intellectual property (IP) company. The Company is focused on the commercialization of its biomedical polymer technology, components and medical devices. The Company has developed biostable, implantable polymers, including Elast-Eon and ECSil, which are long-term implantable co-polymers. Its Elast-Eon technology is available in a range of mechanical properties (Elastomers to rigid polymers), 70 Shore A to 80 Shore D. Its ECSil technology is available in a range of mechanical properties, but extends the softer materials to 70 Shore A. The Company has developed Elast-Eon and Reaction Injection Molding (RIM) technology for use in high-precision medical device components. Its polymers are developed and used in cardiology and urological applications, including pacing leads, cardiac cannulae, stents and neuro stimulation devices.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.